TOLERATE Events
TOLERATE 3rd Annual Meeting in Budapest, Hungary - November 10-12, 2025
Febraury 11, 2025
The following training modules will be delivered: TRANS4 “Acquisition of R&D funding” and TRANS5 “Gender dimension”. Moreover, we’ll have the usual DCs’ presentations and the Supervisory Board Meeting.
TOLERATE 2nd Progress Meeting in Dublin, Ireland - May 12-14, 2025
Febraury 11, 2025
Alongside the usual progress meeting, which includes presentations from DCs and the Supervisory Board Meeting, we will also hold the training module CLIN3: "The impact and role of standardized databases and biomarker testing for long-term follow-up clinical studies of iTTP patients", featuring some of you (AP-HP, SMW) as speakers. Additionally, we will have the TRANS3 module: "Communicating with your stakeholders."
TOLERATE 2nd Annual Meeting, organised by AHT and INN-ACTA in Barcelona - December 2-4, 2024
December 4, 2024
From December 2nd to 4th, the TOLERATE Doctoral Candidates and project Partners came together for the 2nd Annual Meeting in Barcelona. Organized by AHT and INN-ACTA, the meeting included engaging training sessions on “Key Enabling Technologies” and a Biostatistics Workshop. The attendees also had the unique opportunity to visit the Werfen Company, an associated partner in Barcelona. The Doctoral Candidates showcased their progress through presentations, collaborated with one another, and shared their personal experiences in the project, making it a valuable and enriching experience for all involved.
2nd Progress Meeting and Mid-term Meeting on 21-24 May in Antwerp
May 29, 2024
Last week, from the 21st to the 24th of May, the TOLERATE consortium convened in Antwerp, Belgium, for the 2nd Progress Meeting and Mid-Term Meeting. The 8 TOLERATE Doctoral Candidates and their supervisors attended and greatly contributed to the success of the meeting organised by anicells and INN-ACTA. We were privileged to have the EU Project Officer, Giuliana Donini, in attendance for the Mid-term meeting. Witnessing everyone’s dedication and enthusiasm as we reviewed the latest research progress from our students was truly inspiring. Together with the presentations from DCs, the meeting also included the Transferable skill courses on “Managing innovation, knowledge and data” and “Clinical development of novel therapies of TTP and the impact and role of in vitro diagnostics on patient selection and trail enrichment” and a visit at anicells facilities in Niel.
SAVE THE DATE - Progress Meeting and Mid-term Meeting on 21-24 May in Antwerp
February 07, 2024
TOLERATE Progress Meeting and Mid-term Meeting with the EU Project Officer will be held on 21-24 May in Antwerp.
TOLERATE 1st Annual Meeting, organised by SNQ and INN-ACTA in Amsterdam, November 20-22, 2023
November 25, 2023
On November 20-22, the TOLERATE Doctoral Candidates and all the Partners joined the 1st Annual Meeting in Amsterdam. The meeting was organised by SNQ and INN-ACTA and included the training courses on “Immunology, autoimmunity and immunotolerance”, “Addressing ethical, administrative, regulatory and legal aspects”, “Open Science and FAIR Data” and a very interesting and interactive hands-on training on “Advanced Flow Cytometry & Microscopy (Airyscan & Image Stream)”. Moreover, the DCs presented their progresses and spent high quality time together - a chance to meet, work together and share their personal experiences within the Project.
TOLERATE meets the B-specific project, November 20-22, 2023
October 24, 2023
TOLERATE members Karen Vanhoorelbeke and Nick Geukens (KU Leuven, PharmAbs, Belgium), Anja Feldmann and Michael Bachmann (HZDR, Germany), and INN-ACTA (Italy) joined the B-Specific (inserire link https://www.bspecific.eu/) coordinated by Amanda Foks (Universiteit Leiden, the Netherlands). B-specific is a HorizonEIC-2022-pathfindechallenge grant focused on B-CELL RELATED GENE AND PROTEIN MARKERS WITH PROGNOSTIC AND THERAPEUTIC VALUE FOR CVD. The kick off meeting took place in Leiden on October 23, 2023. Happy to be part go the B-specific consortium and to contribute to auto antigen discovery and development of UniCAR T cell therapy.
TOLERATE 1st Network Meeting, organised by AP-HP and INN-ACTA in Paris May 23-24, 2023
May 23-24, 2023
The TOLERATE 1st Network Meeting meeting was a huge success! The meeting took place in Paris, on the 23rd and 24th of May. Representants from the 8 beneficiaries and 4 Associated Partners attended the meeting together with, for the first time, the 8 Doctoral Candidates (DCs) recruited in the project. The meeting was an opportunity for all the members and the DCs to get to know each other, and to review the management and implementation of the project. Moreover, the first training module was delivered with very interesting talks about the “Clinical management of iTTP and current clinical decision making.
TOLERATE Kick Off Meeting, organised by KUL and INN-ACTA, Leuven
November 8-9, 2022
The TOLERATE Kick OFF Meeting, held in Leuven, Belgium, on 8 and 9 November 2022, marked the official start of the Project. The meeting was an opportunity for everyone to get to know each other, share project’s vision and discuss the overall research and training plan. The Kick Off meeting also offered the occasion for the TOLERATE Partners to meet with the REA Project Officer for the project.
